Global Varicose Veins Treatment Devices Market Boosted by New Advancements
Posted by Andrew Thomas on April 9th, 2019
Varicose veins typically form in the leg and arises from the flow of blood in the opposite direction. This creates considerable pressure in the already blocked veins. Varicose veins can result in ulceration, swelling, and venous eczema, and the disease can significantly hamper the quality of life of the incumbent. Clinical studies reveal that almost 40% of total population in the U.S. is affected by varicose veins and approximately 30 million U.S. citizens suffer from and possess the risk of developing varicose veins disease. For treating the aberration, several invasive techniques such as sclerotherapy, laser ablation and laser and intense-pulsed therapy are used.
Advancements in Treatment for Varicose Veins
However, the global varicose veins treatment devices market is gradually shifting toward minimally-invasive treatment methods like medical adhesives, which eliminates the need for anesthesia administration and causes relatively less bruising when compared to laser-based treatment methods.
Endovenous thermal ablation (EVTA) has emerged as a critical treatment procedure for successfully treating both great and small saphenous veins and long-term maintenance of vein closure. The procedure is far more advanced than surgery as it typically eliminates the need for general anesthesia and inpatient treatment and causes far less postoperative pain.
VenaSeal is another technique, which is in vogue for treating varicose veins. In this procedure, a unique type of glue is injected into the damaged or unhealthy vein. Once in the vein, it forms a sealed barrier to relieve any symptoms related to varicose or spider veins. The symptoms are relieved as the body reroutes the blood to nearby veins that are often stronger and healthier.
Which are the biggest markets for Varicose Veins Treatment Devices?
North America is the largest market for varicose vein treatment devices owing to the large patient pool. According to the varicose veins treatment devices market analysis, an estimated 3.7 million people suffer from varicose veins in Canada. This is mostly due to the demographic shift toward geriatric population and high prevalence of obesity. An estimated 1 million people are treated for varicose veins in the region, and this suggests the under-penetration of the market in the country. Europe is the second largest market for varicose veins treatment devices as the disease affects almost 35% of the European population. Growth in aging population and prevalence of obesity are the primary factors for the increase in the number of patients suffering from varicose veins, and the treatment devices market for varicose veins is projected to witness considerable growth in North America and Europe.
Countries in the Asia-Pacific region such as China and India constitute significant market for varicose vein treatment devices. According to a research study, 7% of Indian population is suffering from varicose veins. The study also reveals that 10% of the male population in China suffers from varicose veins, while for women the figure is an astounding 29%. Asia Pacific region is expected to generate considerable growth for the varicose vein treatment devices market, owing to the rising geriatric population, coupled with improving healthcare infrastructure and rise in awareness among people about early treatment methods.
Our related topic:
Treatments Available in The Varicose Veins Treatment Devices Market
Home Treatments Compete With The Global Varicose Veins Treatment Devices Market
Why is The Global Varicose Veins Treatment Devices Market Growing?
What Aids the Global Varicose Veins Treatment Devices Market?
